Ibrutinib (Imbruvica®) for the treatment of adult patients with previously untreated chronic lymphatic leukaemia (CLL)
Wijma S, de Boer JE
Record ID 32018001626
Dutch
Original Title:
Package advice for ibrutinib (Imbruvica®)
Details
Project Status:
Completed
Year Published:
2020
URL for published report:
https://english.zorginstituutnederland.nl/publications/reports/2020/07/03/ibrutinib-imbruvica-for-the-treatment-of-adult-patients-with-previously-untreated-chronic-lymphatic-leukaemia-cll
English language abstract:
An English language summary is available
Publication Type:
Other
Country:
The Netherlands
MeSH Terms
- Leukemia, Lymphocytic, Chronic, B-Cell
- Anti-Infective Agents
- Pyrazoles
- Pyrimidines
- Long Term Adverse Effects
Contact
Organisation Name:
The National Health Care Institute (ZIN, Zorginstituut Nederland)
Contact Address:
Postbus 320, NL-1110 AH Diemen The Netherlands
Contact Name:
Timon Sibma
Contact Email:
TSibma@zinl.nl
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.